Delayed heart block after temporary balloon occlusion of a secundum atrial septal defect.
Delayed heart block after temporary balloon occlusion of a secundum atrial septal defect.
复制标题
继发孔房间隔缺损临时球囊闭塞后延迟性心脏传导阻滞。
DOI:
10.1161/circep.108.818450
复制
发表时间:
2008
期刊:
影响因子:
--
通讯作者:
Das,Saumya
中科院分区:
文献类型:
--
作者:
Singh,SheldonM;Das,Saumya
Although the association between atrial arrhythmias and atrial septal defects (ASD) has been well described, abnormalities of AV nodal conduction, typically in the setting of ASD device closure, have been infrequently reported. 1–4 We report a case of transient complete heart block several hours after temporary balloon occlusion of a secundum ASD. To our knowledge, this is the first report describing delayed complete heart block with temporary balloon occlusion of an ASD.A 35-year-old woman with Eisenmenger’s syndrome secondary to a secundum ASD and anomalous pulmonary venous drainage was hospitalized with a Hickman line infection. The decision was made to remove the line, given the presence of vegetations and septic pulmonary emboli. To avoid systemic vegetation embolization, temporary occlusion of the ASD at the time of the line removal was planned. The patient had no prior history of heart block and a normal PR interval on a baseline ECG (Figure, panel A). A 34-mm Amplatzer balloon was placed across the ASD and inflated (waist diameter 16 mm) to occlude flow between the right and left atria (panel B). The balloon remained inflated for 25 minutes during manipulation and removal of the Hickman line. No intraprocedural hemodynamic or conduction abnormalities were noted. Eighteen hours after the procedure the patient experienced syncope with documented high-grade AV block (panel C). The episode persisted for 3 minutes with spontaneous resumption of normal AV conduction. She was monitored with in-hospital telemetry for an additional 7 days and with an outpatient event monitor for 21 days. There were no further episodes of AV block. Transient AV block has been described as a complication of ASD device closure. 1, 2 In the largest series to date, 3.1% and 0.6% of patients developed transient second and third